SCHEMBL597404

SCHEMBL597404

Cc1ccn(N)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13547964 0.67
SCHEMBL1257109 0.67 CDK8 (0.33)
SCHEMBL1762078 0.67
SCHEMBL292333 0.67
SCHEMBL3820811 0.67
Formamide SCHEMBL10967419 0.64 KEAP1 (0.39)
SCHEMBL255119 0.63
SCHEMBL1353764 0.62 HTT (0.56)
SCHEMBL24159152 0.62 THRB (0.49)
SCHEMBL2551980 0.62 KMT2A (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111094232-A P-phenylenediamine color bases F having an aliphatic chain and trialkylammonium groups and use thereof for oxidation dyeing of keratin fibers 莱雅公司 2020-05-01 CN claimed
JP-60215687-A None JP disclosed
EP-4331585-A2 INHIBITORS OF RET Blueprint Medicines Corporation (US) 2024-03-06 EP disclosed
EP-4292594-A2 INHIBITORS OF RET Blueprint Medicines Corporation (US) 2023-12-20 EP disclosed
WO-2023240138-A1 INDAZOLE CONTAINING MACROCYCLES AND THEIR USE BLOSSOMHILL THERAPEUTICS, INC. (US) 2023-12-14 WO disclosed
EP-3371171-B1 INHIBITORS OF RET BLUEPRINT MEDICINES CORP (US) 2023-10-25 EP disclosed
US-20230292759-A1 PHENYL COMPOUND AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-09-21 US disclosed
CN-111423416-B Inhibitors of RET 缆图药品公司 2023-05-26 CN disclosed
CN-115873000-A Isoquinolone and quinazolinone compounds, and composition and application thereof 中山医诺维申新药研发有限公司 2023-03-31 CN disclosed
CN-115448922-A Free base crystal form containing pyrazole polycyclic derivative and preparation method and application thereof 上海翰森生物医药科技有限公司 2022-12-09 CN disclosed
EP-1928456-A2 SUBSTITUTED PYRAZOLE COMPOUNDS Miikana Therapeutics, Inc. (US) 2008-06-11 EP disclosed
US-7345038-B2 Pyridyloxymethyl and benzisoxazole azabicyclic derivatives PFIZER, INC (US) 2008-03-18 US disclosed
CN-1993360-A Condensed pyridines as kinase inhibitors PALAU PHARMA SA (ES) 2007-07-04 CN disclosed
US-20070142368-A1 Substituted pyrazole compounds MIIKANA THERAPEUTICS, INC. 2007-06-21 US disclosed
WO-2007041358-A2 SUBSTITUTED PYRAZOLE COMPOUNDS MIIKANA THERAPEUTICS, INC. (US) 2007-04-12 WO disclosed
EP-1608648-A1 PYRIDYLOXYMETHYL AND BENZISOXAZOLE AZABICYCLIC DERIVATIVES Pfizer Products Inc. (US) 2005-12-28 EP disclosed
US-20050026922-A1 For treating CNS or other disorders, including concurrent treatment of disorders such as schizophrenia and depression; side effect reduction; for example, (7R,9aS)-trans-7-[6-(2,6-Dimethyl-piperidin-1-ylmethyl)-pyridin-2-yloxymethyl]-2-(5-fluoro-benzo[d]isoxazol-3-yl)-octahydro-pyrido[1,2-a]pyrazine PFIZER INC 2005-02-03 US disclosed
WO-2004081007-A1 PYRIDYLOXYMETHYL AND BENZISOXAZOLE AZABICYCLIC DERIVATIVES PFIZER PRODUCTS INC. (US) 2004-09-23 WO disclosed
JP-S60215687-A PRODUCTION OF PYRAZOLO(1,5-B)(1,2,4)TRIAZOLE DERIVATIVE FUJI PHOTO FILM CO LTD 1985-10-29 JP disclosed
US-4275073-A PENTATHIEPINOPYRAZOLES AND PYRAZOLOTRITHIOCARBONATES E. I. DU PONT DE NEMOURS AND COMPANY (US) 1981-06-23 US disclosed